ArticleNanotechnology, science and applications2026
Development of Biocompatible Ciprofloxacin-Loaded Zinc-Bovine Serum Albumin Nanoflowers as Nontoxic Platform for Local Drug Delivery.
Article in Nanotechnology, science and applications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Osteomyelitis (OM) is an inflammation of bone and bone marrow and remains one of the most challenging infectious diseases to treat. This clinical difficulty highlights the need for alternative therapeutic strategies, including targeted local delivery of antibacterial agents. In this study, we report for the first time the use of zinc-bovine serum albumin (ZnBSA) hybrid nanoflowers as potential antibiotic carriers for osteomyelitis treatment. Hybrid nanoflowers are hierarchically structured nanomaterials composed of inorganic components (typically metal phosphates) and organic molecules (such as proteins or enzymes) that self-assemble into flower-like morphologies, exhibiting high surface area and synergistic physicochemical properties arising from organic-inorganic integration. Methods: ZnBSA hybrid nanostructures were synthesized through a rapid and optimized procedure and characterized using scanning electron microscopy, infrared spectroscopy and X-ray diffraction. Ciprofloxacin was loaded into the ZnBSA nanostructures, and drug release behavior was studied by ultraviolet-visable spectroscopy. Antibacterial activity was assessed using optical density measurements and disc diffusion assays. The biocompatibility of ZnBSA loaded with ciprofloxacin was evaluated through in vitro toxicity assays on human red blood cells and dermal fibroblasts, as well as in vivo testing using Results: The ZnBSA nanostructures demonstrated rapid formation and improved biocompatibility compared to conventional copper-based nanoflowers. Toxicity studies confirmed a favorable safety profile both in vitro and in vivo. Ciprofloxacin-loaded ZnBSA carriers exhibited sustained drug release and effective antibacterial activity against Discussion: These findings indicate that ZnBSA hybrid nanostructures represent a safe and effective localized drug delivery system for osteomyelitis treatment. Their biocompatibility, rapid synthesis, sustained antibiotic release, and broad-spectrum antibacterial activity highlight their potential as a promising alternative to existing nanocarrier systems for managing bone infections.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.